Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.460
-0.030 (-2.01%)
At close: Feb 21, 2025, 4:00 PM
1.450
-0.010 (-0.67%)
After-hours: Feb 21, 2025, 6:48 PM EST
Lucid Diagnostics Employees
Lucid Diagnostics had 70 employees as of December 31, 2023. The number of employees decreased by 4 or -5.41% compared to the previous year.
Employees
70
Change (1Y)
-4
Growth (1Y)
-5.41%
Revenue / Employee
$59,843
Profits / Employee
-$747,343
Market Cap
80.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
LUCD News
- 2 days ago - Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health - PRNewsWire
- 4 days ago - PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement - PRNewsWire
- 16 days ago - Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - PRNewsWire
- 5 weeks ago - Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - PRNewsWire
- 2 months ago - Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PRNewsWire
- 2 months ago - Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters - PRNewsWire
- 2 months ago - Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication - PRNewsWire
- 2 months ago - Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones - PRNewsWire